Valuation: Proto Script Pharmaceutical Corp.

Market Cap 19.66L 17.93L 16.57L 14.96L 28.17L 18Cr 29.28L 2Cr 79.13L 9.91Cr 73.74L 72.2L 31Cr P/E 2015 *
-
P/E 2016 -41.4x
Enterprise Value 20.13L 18.36L 16.98L 15.32L 28.86L 19Cr 29.99L 2.05Cr 81.05L 10Cr 75.53L 73.95L 32Cr EV / Sales 2015 *
-
EV / Sales 2016 394x
Free-Float
89.82%
Yield 2015 *
-
Yield 2016 -
Current year 0
Extreme 0.0001
0
1 year 0
Extreme 0.0001
0
3 years 0
Extreme 1.0E-6
0
5 years 0
Extreme 1.0E-6
0.02
10 years 0
Extreme 1.0E-6
2.2
Manager TitleAgeSince
Chief Executive Officer 58 29/06/2016
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--%-66.67%+9,900.00% 5.69T
-0.37%-2.43%+29.28%+66.38% 78TCr
-0.09%-2.31%+20.71%+62.05% 8.82TCr
+0.54%-5.43%+35.96%+126.27% 6.74TCr
-0.38%-2.67%-4.63%+2.39% 4.81TCr
-0.38%-7.83%+37.07%+35.78% 4.78TCr
-2.94%-5.35%-1.40%-51.26% 3.22TCr
-0.27%-3.44%+30.79%+19.84% 3.29TCr
+0.87%-30.86%+18.14%+464.73% 3.13TCr
+0.64%-1.46%+66.88%+95.53% 2.91TCr
Average +0.40%-5.05%+16.61%+1,072.17% 12TCr
Weighted average by Cap. -0.10%-3.24%+27.77%+72.53%

Financials

2015 2016
Net sales 9L 8L 7L 7L 12.63L 8.24Cr 13.13L 89.77L 35.48L 4.45Cr 33.07L 32.38L 14Cr 8L 7L 7L 6L 11.31L 7.37Cr 11.75L 80.35L 31.76L 3.98Cr 29.6L 28.98L 13Cr
Net income -1L -1L -1L -1L -2L -1.36Cr -2L -14.79L -6L -73.26L -5L -5L -2.31Cr -71.83L -65.51L -60.57L -54.66L -1.03Cr -67Cr -1.07Cr -7.31Cr -2.89Cr -36Cr -2.69Cr -2.64Cr -114.4Cr
Net Debt 27.07T 24.69T 22.83T 20.6T 38.8T 25.29L 40.32T 3L 1L 13.65L 1L 99.42T 43.11L 47.78T 43.58T 40.29T 36.36T 68.48T 44.65L 71.18T 5L 2L 24.1L 2L 2L 76.1L
Logo Proto Script Pharmaceutical Corp.
Proto-Script Pharmaceuticals, Corp., formerly Yanex Group, Inc. is a development-stage company. The Company is primarily in the business of repair power wheelchairs and scooters, which are classified as durable medical equipment (DME) products and reimbursable by healthcare insurance providers. The Company has various contracts with state and governmental insurance providers, among others. These contracts provide the Company the right to sell and repair DME. The Company's health care insurance contracts allow it the ability to service patients nationally. The Company intends to expand its market through additional contracts and open several repair facilities throughout the continental United States. The Company currently has repair facilities in Las Vegas, Nevada, Rancho-Cucamonga, and Anaheim, California. As of June 30, 2016, the Company had not generated any revenues.
Employees
13
  1. Stock Market
  2. Stocks
  3. PSCR Stock